electroCore, Inc. (ECOR)
USD 5.87
(-11.33%)
USD 5.87
(-11.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 32.03 Million USD | 7.31% |
| 2022 | 29.85 Million USD | 23.81% |
| 2021 | 24.1 Million USD | -7.42% |
| 2020 | 26.04 Million USD | -42.54% |
| 2019 | 45.32 Million USD | -17.54% |
| 2018 | 54.96 Million USD | 111.92% |
| 2017 | 25.93 Million USD | 71.31% |
| 2016 | 15.14 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.4 Million USD | 4.66% |
| 2024 Q2 | 7.89 Million USD | -6.09% |
| 2023 Q1 | 8.51 Million USD | 8.7% |
| 2023 Q4 | 8.02 Million USD | 0.71% |
| 2023 FY | 32.03 Million USD | 7.31% |
| 2023 Q3 | 7.97 Million USD | 0.24% |
| 2023 Q2 | 7.95 Million USD | -6.63% |
| 2022 Q1 | 7.12 Million USD | 6.73% |
| 2022 FY | 29.85 Million USD | 23.81% |
| 2022 Q4 | 7.83 Million USD | 7.74% |
| 2022 Q3 | 7.27 Million USD | -4.53% |
| 2022 Q2 | 7.61 Million USD | 7.01% |
| 2021 Q3 | 5.11 Million USD | -16.08% |
| 2021 Q4 | 6.67 Million USD | 30.37% |
| 2021 FY | 24.1 Million USD | -7.42% |
| 2021 Q1 | 6.22 Million USD | -3.25% |
| 2021 Q2 | 6.09 Million USD | -2.02% |
| 2020 Q4 | 6.43 Million USD | 23.18% |
| 2020 Q1 | 8.08 Million USD | -9.07% |
| 2020 FY | 26.04 Million USD | -42.54% |
| 2020 Q2 | 6.3 Million USD | -22.02% |
| 2020 Q3 | 5.22 Million USD | -17.16% |
| 2019 Q2 | 11.89 Million USD | -17.73% |
| 2019 FY | 45.32 Million USD | -17.54% |
| 2019 Q1 | 14.46 Million USD | -8.79% |
| 2019 Q3 | 10.41 Million USD | -12.44% |
| 2019 Q4 | 8.89 Million USD | -14.67% |
| 2018 Q3 | 13.6 Million USD | -16.91% |
| 2018 FY | 54.96 Million USD | 111.92% |
| 2018 Q4 | 15.85 Million USD | 16.54% |
| 2018 Q1 | 9.13 Million USD | 22.73% |
| 2018 Q2 | 16.37 Million USD | 79.32% |
| 2017 Q1 | 4.78 Million USD | 0.0% |
| 2017 Q2 | 7.56 Million USD | 58.16% |
| 2017 Q3 | 6.14 Million USD | -18.84% |
| 2017 Q4 | 7.43 Million USD | 21.11% |
| 2017 FY | 25.93 Million USD | 71.31% |
| 2016 FY | 15.14 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -185.38% |
| Cerus Corporation | 143.15 Million USD | 77.625% |
| OrthoPediatrics Corp. | 137.01 Million USD | 76.623% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -181.942% |
| Talis Biomedical Corporation | 67.18 Million USD | 52.325% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -28.401% |
| Inogen, Inc. | 236.08 Million USD | 86.432% |
| Spectral AI, Inc. | 20.86 Million USD | -53.523% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 42.799% |
| CVRx, Inc. | 76.14 Million USD | 57.933% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -807.909% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -156.474% |
| Orthofix Medical Inc. | 667.42 Million USD | 95.201% |
| Venus Concept Inc. | 80.47 Million USD | 60.198% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 43.386% |
| Bioventus Inc. | 409.91 Million USD | 92.186% |
| BrainsWay Ltd. | 28.01 Million USD | -14.323% |
| Envoy Medical, Inc. | 17.89 Million USD | -78.964% |
| IceCure Medical Ltd | 16.87 Million USD | -89.802% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 24.512% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -81.653% |
| MaxCyte, Inc. | 84.84 Million USD | 62.248% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -158.07% |
| Nexalin Technology, Inc. | 5.78 Million USD | -454.04% |
| PAVmed Inc | 64.82 Million USD | 50.59% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 37.29% |
| RxSight, Inc. | 103.85 Million USD | 69.156% |
| Sight Sciences, Inc. | 126.44 Million USD | 74.669% |
| SI-BONE, Inc. | 156.35 Million USD | 79.513% |
| TELA Bio, Inc. | 84.18 Million USD | 61.953% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 54.278% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 84.25% |
| LivaNova PLC | 843.54 Million USD | 96.203% |
| 908 Devices Inc. | 68.08 Million USD | 52.951% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 93.377% |
| Nemaura Medical Inc. | 7.13 Million USD | -348.689% |
| NeuroPace, Inc. | 75.29 Million USD | 57.46% |
| LENSAR, Inc. | 33.33 Million USD | 3.915% |
| Apyx Medical Corporation | 51.01 Million USD | 37.216% |
| Cutera, Inc. | 197.72 Million USD | 83.8% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -29.256% |
| BioSig Technologies, Inc. | 28.53 Million USD | -12.271% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 83.271% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 11.173% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 96.17% |
| Axonics, Inc. | 270.2 Million USD | 88.146% |
| Outset Medical, Inc. | 198.77 Million USD | 83.885% |
| IRIDEX Corporation | 31.81 Million USD | -0.682% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 82.227% |
| IRadimed Corporation | 30.12 Million USD | -6.335% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -275.422% |
| INVO Bioscience, Inc. | 7.85 Million USD | -307.867% |
| Telesis Bio, Inc. | 63.48 Million USD | 49.549% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 67.466% |
| Varex Imaging Corporation | 224.8 Million USD | 85.751% |
| Quipt Home Medical Corp. | 148.66 Million USD | 78.455% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -173.232% |
| Pulmonx Corporation | 112.68 Million USD | 71.575% |
| Dynatronics Corporation | 9.9 Million USD | -223.283% |
| Modular Medical, Inc. | 17.52 Million USD | -82.731% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -58.671% |
| Semler Scientific, Inc. | 38.94 Million USD | 17.751% |
| InMode Ltd. | 215.68 Million USD | 85.149% |
| Bruker Corporation | 1.07 Billion USD | 97.024% |
| Cytosorbents Corporation | 48.33 Million USD | 33.734% |
| DexCom, Inc. | 1.69 Billion USD | 98.106% |
| Align Technology, Inc. | 2.07 Billion USD | 98.458% |
| Viveve Medical, Inc. | 22.17 Million USD | -44.459% |
| ZimVie Inc. | 275.12 Million USD | 88.358% |
| Movano Inc. | 29.69 Million USD | -7.885% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 76.666% |
| Nexalin Technology, Inc. | 5.78 Million USD | -454.04% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -807.909% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 94.67% |
| Profound Medical Corp. | 33.6 Million USD | 4.679% |
| Insulet Corporation | 939.9 Million USD | 96.592% |
| enVVeno Medical Corporation | 25.23 Million USD | -26.916% |
| Surmodics, Inc. | 98.69 Million USD | 67.546% |
| iCAD, Inc. | 22.22 Million USD | -44.121% |
| Nuwellis, Inc. | 22.61 Million USD | -41.649% |
| Biotricity, Inc. | 17.18 Million USD | -86.394% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 92.816% |
| Aethlon Medical, Inc. | 12.27 Million USD | -160.892% |
| InspireMD, Inc. | 22.95 Million USD | -39.569% |
| PAVmed Inc. | 64.82 Million USD | 50.59% |
| BIOLASE, Inc. | 34.66 Million USD | 7.588% |
| Beyond Air, Inc. | 61.7 Million USD | 48.086% |
| FONAR Corporation | 28.6 Million USD | -11.978% |
| AxoGen, Inc. | 149.33 Million USD | 78.551% |
| Vivani Medical, Inc. | 26.96 Million USD | -18.787% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 81.913% |
| Inari Medical, Inc. | 448.59 Million USD | 92.86% |
| UFP Technologies, Inc. | 58.08 Million USD | 44.859% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -550.033% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -406.957% |
| Tenon Medical, Inc. | 16.96 Million USD | -88.773% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -333.261% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 27.372% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.029% |
| Sintx Technologies, Inc. | 15.2 Million USD | -110.716% |
| NanoVibronix, Inc. | 4.97 Million USD | -544.098% |
| Quanterix Corporation | 118.1 Million USD | 72.878% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -173.232% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -121.791% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 91.843% |
| TransMedics Group, Inc. | 182.82 Million USD | 82.479% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -14.131% |
| NeuroMetrix, Inc. | 11.09 Million USD | -188.595% |
| Hyperfine, Inc. | 52.87 Million USD | 39.418% |
| Establishment Labs Holdings Inc. | 172 Million USD | 81.378% |
| Biomerica, Inc. | 6.97 Million USD | -359.028% |
| Bone Biologics Corporation | 9.42 Million USD | -239.732% |
| AVITA Medical, Inc. | 80.77 Million USD | 60.347% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -210.642% |
| Silk Road Medical, Inc | 186.35 Million USD | 82.812% |